Close Menu

NEW YORK (GenomeWeb) – Natera went public late last week, raising $180 million in an initial public offering on the Nasdaq Global Select Market.

The San Carlos, California-based reproductive health molecular diagnostics firm offered 10 million shares of common stock at an offering price of $18 per share. The underwriters on the offering — Morgan Stanley, Cowen and Co., Piper Jaffray, R.W. Baird, and Wedbush Securities — have an over-allotment option to purchase an additional 1.5 million shares.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.